Evommune, Inc. Common Stock (EVMN)
EBITDA Growth
-160.43%
Quarterly · Period ending:
EVMN EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported-160.43%period ending
Latest reported-160.43%period ending
EVMN Quarterly EBITDA YoY % (-466.59% → -160.43%)
Year-over-year change
High-resolution chart · PNG
EVMN ebitda growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Growth |
|---|---|
| -160.4307% | |
| -66.5138% | |
| -63.6323% | |
| 19.5786% | |
| 51.2459% | |
| -466.5867% |